Oklo
OKLO
$58.58
+8.60%
Oklo Inc. is a pre-revenue nuclear energy company developing compact, liquid metal fast reactor power plants to provide clean, reliable, and affordable energy at scale, operating within the regulated electric utility sector. The company is a technology disruptor, pioneering a novel approach to nuclear fission with its Aurora powerhouse product line designed to run on recycled nuclear fuel. The current investor narrative is intensely focused on the company's progress through a lengthy and complex regulatory gauntlet, with recent news highlighting key regulatory approvals juxtaposed against the stock's significant volatility, as the market debates the timeline to commercialization and the immense capital requirements before any revenue generation.…
OKLO
Oklo
$58.58
Related headlines
Investment Opinion: Should I buy OKLO Today?
Rating & Thesis: Hold. Oklo is a highly speculative, binary bet on regulatory success and future commercialization, unsuitable for most investors. The lack of analyst consensus targets underscores the extreme uncertainty.
Supporting Evidence: The company has no traditional valuation metrics (PS=0, PE=-99.4) and is burning cash at a rate of -$115.4 million TTM. While the $788.4 million cash position is strong, the widening quarterly losses (-$9.8M to -$41.4M in 2025) indicate the burn is accelerating. The stock's -65.85% six-month decline reflects a market re-rating this risk, despite recent regulatory progress and the strategic Meta partnership.
Risks & Conditions: The two biggest risks are regulatory failure and dilution from future capital raises. This Hold rating would upgrade to a speculative Buy only on confirmation of final NRC approval and a clear, funded path to the first plant's construction. It would downgrade to Sell if cash burn accelerates beyond $50M per quarter or if the stock breaks below its $19.89 support level. The stock is overvalued on any conventional metric but fairly valued only within the context of its extreme, binary option-like risk/reward profile.
Sign up to view all
OKLO 12-Month Price Forecast
Oklo's 12-month outlook is dominated by regulatory uncertainty and capital preservation. The base case (50% probability) is a continued volatile drift with the stock trapped between its cash-backed book value and the overwhelming skepticism of a market waiting for concrete milestones. The bull case requires a flawless regulatory outcome, while the bear case is a tangible risk given the company's pre-revenue status and history of stock price collapse. The stance is neutral because the risk/reward is balanced only for investors with a very high risk tolerance and a multi-year horizon; any positive price action will likely be sold into until revenue generation is imminent.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Oklo's 12-month outlook, with a consensus price target around $76.15 and implied upside of +30.0% versus the current price.
Average Target
$76.15
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$47 - $76
Analyst target range
Insufficient analyst coverage available in the provided dataset to determine a consensus price target, recommendation distribution, or target range. The institutional ratings data shows six firms providing actions, with a mix of Buy, Overweight, and Neutral ratings as of March 2026, but no specific price targets are included. The implication of limited target data is that Oklo remains a highly speculative, story-driven investment with high uncertainty, typical for a pre-revenue company in a complex, long-cycle industry; the wide dispersion in analyst views (from Buy to Neutral) further underscores the binary nature of the investment case centered on regulatory success and eventual execution.
Bulls vs Bears: OKLO Investment Factors
The bear case currently holds stronger evidence, grounded in the harsh reality of zero revenue, accelerating losses, and a stock price in freefall despite regulatory wins. The most important tension in the investment debate is the clash between long-term technological promise and near-term financial incineration. While the company has a strong cash position and strategic tailwinds, the market is punishing the uncertainty of the timeline to revenue and the high probability of further dilution before any income is generated.
Bullish
- Strong Cash Position: Oklo holds $788.4 million in cash with a robust current ratio of 49.1, providing a multi-year runway to fund its development and regulatory process. This liquidity is critical for a pre-revenue company facing a long path to commercialization.
- Key Regulatory Progress: Recent news highlights the company securing two critical regulatory approvals, positioning it closer to its first commercial deployments. This progress is essential for the binary investment thesis centered on final NRC approval.
- Strategic Meta Partnership: The deal with Meta provides crucial funding validation and a long-term customer for future power, addressing the AI industry's soaring energy demands. This partnership de-risks the initial commercial deployment and future revenue stream.
- Massive Market Tailwind: Geopolitical energy volatility and the AI-driven power crunch create a powerful, secular tailwind for next-generation nuclear power. Oklo's technology, designed to run on recycled fuel, is positioned as a solution to these macro trends.
Bearish
- Pre-Revenue with No Timeline: The company has zero revenue, with estimated first revenue of $315.3 million still years away (news suggests at least 2030). The market cap of $10.5 billion is a purely speculative bet on future success with no current financial foundation.
- Accelerating Cash Burn: Quarterly net losses widened from -$9.8M in Q1 2025 to -$41.4M in Q4 2025, with TTM free cash flow at -$115.4 million. This accelerating burn rate threatens the cash runway and implies future dilutive equity raises are highly likely.
- Severe Technical Downtrend: The stock is in a severe downtrend, down 65.85% over six months and 52.28% over three months, trading at just 26% of its 52-week range. This persistent selling pressure reflects a loss of investor confidence despite regulatory progress.
- Binary Regulatory Risk: The investment thesis hinges entirely on final NRC approval for commercial operation, a process known for complexity and delay. Recent news notes the stock fell despite progress because the market is focused on this still-pending, critical approval.
OKLO Technical Analysis
The prevailing price trend is a severe and sustained downtrend from post-IPO highs, with the stock down 65.85% over the last six months, despite a positive 1-year change of 121.17%. The current price of $50.25 sits at just 26% of its 52-week range ($19.89 to $193.84), positioning it much closer to its 52-week low, which suggests a deeply oversold condition but also reflects significant fundamental and sentiment challenges. Recent momentum is decisively negative and accelerating the longer-term decline, with the stock down 19.93% over the past month and 52.28% over the past three months, indicating a severe loss of momentum and persistent selling pressure. The stock's beta of 0.943 suggests its volatility is slightly below the market's, yet its massive drawdown of -73.83% and relative weakness metrics (e.g., -50.18 vs. SPY over 3 months) show it has been a significant underperformer driven by company-specific factors. Key technical support is clearly defined at the 52-week low of $19.89, while resistance is far overhead at the 52-week high of $193.84; a breakdown below the $20 level would signal a catastrophic loss of confidence, while any sustained move above the recent downtrend would require a fundamental catalyst like final NRC approval.
Beta
0.94
0.94x market volatility
Max Drawdown
-73.8%
Largest decline past year
52-Week Range
$20-$194
Price range past year
Annual Return
+159.8%
Cumulative gain past year
| Period | OKLO Return | S&P 500 |
|---|---|---|
| 1m | +0.4% | +4.9% |
| 3m | -39.0% | +0.6% |
| 6m | -63.9% | +5.1% |
| 1y | +159.8% | +28.8% |
| ytd | -24.7% | +1.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OKLO Fundamental Analysis
Oklo has no revenue trajectory to analyze, as its most recent quarterly revenue for Q4 2025 was $0, consistent with every quarter in the provided data, reflecting its pre-commercial, development-stage status. The company is deeply unprofitable, with a Q4 2025 net income of -$41.4 million and an EPS of -$0.27; gross profit was negative -$149k, indicating initial costs associated with its development activities, while operating and net margins are all 0% due to the lack of revenue. Losses have been widening sequentially, with net income deteriorating from -$9.8 million in Q1 2025 to -$41.4 million in Q4 2025 as R&D and G&A expenses scale ahead of commercialization. The balance sheet shows a strong liquidity position with a current ratio of 49.1 and cash of $788.4 million as of Q4 2025, but it is burning cash aggressively with operating cash flow of -$33.4 million and free cash flow of -$60.4 million in that quarter; the debt-to-equity ratio is a minimal 0.00098, indicating funding has come almost entirely from equity raises, but the -$115.4 million TTM free cash flow underscores the massive funding runway required before generating income.
Quarterly Revenue
$0.0B
2025-12
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-115379000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OKLO Overvalued?
Given Oklo's negative net income and EBITDA, the primary valuation metric is the Price-to-Sales (PS) ratio, which is 0 due to the absence of revenue, making traditional multiples inapplicable. The stock's valuation is therefore entirely based on future potential, as evidenced by a market cap of $10.5 billion against zero sales, with forward-looking metrics like the estimated revenue for the next period at $315.3 million providing a glimpse of initial expectations. Peer comparison using standard multiples is not feasible, as the company lacks the revenue and profitability metrics that define the utilities sector; its valuation premium is purely speculative, betting on successful technology commercialization and first revenue generation years into the future. Historically, the stock's own valuation context is limited, but its current market cap represents a significant decline from levels implied during its 2024 public debut, trading far below its post-listing highs and reflecting a market re-rating as the timeline to revenue becomes clearer and capital needs are quantified.
PE
-99.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -455x~0x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-69.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Oklo's primary risk is its complete lack of revenue and accelerating cash burn. Net losses widened sequentially to -$41.4 million in Q4 2025, and with TTM free cash flow of -$115.4 million, the company's $788.4 million cash hoard provides a finite runway. The business model is entirely dependent on successfully navigating a multi-year regulatory gauntlet and then constructing a first-of-its-kind power plant, with any delay or cost overrun directly threatening solvency and necessitating highly dilutive equity raises.
Market & Competitive Risks: The stock's valuation of $10.5 billion for zero sales represents extreme speculative premium, leaving it vulnerable to severe valuation compression if investor patience wanes or interest rates remain elevated. Despite a beta of 0.943, the stock has shown -50.18% relative strength vs. the SPY over three months, indicating company-specific de-rating is already underway. Competitive risks include other advanced nuclear developers (like NuScale) and alternative clean energy sources that may commercialize faster or at lower cost.
Worst-Case Scenario: The worst-case scenario involves a rejection or significant multi-year delay in final NRC approval, coupled with the accelerating cash burn depleting reserves faster than expected. This could trigger a catastrophic loss of confidence, leading the stock to re-test its 52-week low of $19.89. From the current price of $50.25, this represents a realistic downside of approximately -60%. A breakdown below this key technical support could lead to a total capital loss if the company fails to secure additional funding.
FAQ
The key risks are, in order of severity: 1) Regulatory Risk: Failure or multi-year delay in obtaining final NRC approval for commercial operation, which would be catastrophic. 2) Financial Risk: The company is burning cash at a rate of -$115.4 million TTM with zero revenue, making future dilutive equity raises highly likely. 3) Execution Risk: Even with approval, constructing a first-of-its-kind nuclear plant is fraught with technical challenges and cost overruns. 4) Market Risk: As a speculative story stock, it is vulnerable to severe valuation compression if investor sentiment sours further.
The 12-month forecast is highly uncertain, with three distinct scenarios. The base case (50% probability) sees the stock trading between $30 and $70 as regulatory progress continues slowly and dilution occurs. The bull case (20% probability) could see a surge to $120-$193+ on final NRC approval. The bear case (30% probability) could see a collapse to the $20-$30 range on regulatory setbacks or a funding crisis. The most likely outcome is the base case of volatile, range-bound trading driven by news headlines rather than financial results.
OKLO is overvalued by any conventional financial metric, as it has no revenue (PS ratio of 0) and significant losses (PE of -99.4). Its $10.5 billion market cap is a pure speculation on future potential. Compared to its own history, it is undervalued relative to its 52-week high of $193.84, but this reflects a fundamental re-rating rather than a bargain. The valuation implies the market is paying a massive premium for the option on successful commercialization, a bet that is currently out of favor.
OKLO is not a good stock to buy for the vast majority of investors. It is a highly speculative, pre-revenue company with a binary outcome dependent on multi-year regulatory success. The stock has fallen 65.85% in six months despite progress, reflecting extreme risk. It could be a good buy only for a very specific investor: one with a high risk tolerance, a long-term horizon of 5+ years, and who fully understands and can afford the potential for a total loss of capital. For others, it is a clear avoid.
OKLO is strictly a long-term, speculative investment with a minimum horizon of 5-7 years, aligning with its potential commercialization timeline around 2030. It is wholly unsuitable for short-term trading due to its extreme volatility (down 52.28% in 3 months), lack of revenue, and sensitivity to regulatory news flow. The stock pays no dividend and offers no earnings visibility, providing no support for short-term holders. Only investors with patient capital and a venture capital mindset should consider a position.